Table 4.
Estimated pharmacokinetic parameters after oral administration of 120 mg kg−1 acetaminophen to rats.
| Formulation | 00 | 11 | 12 | 13 | 14 |
|---|---|---|---|---|---|
| Route of adm. | iv | PO | PO | PO | PO |
| Dietary component | None | None | Infant formula | Low fat infant formula | Sar |
| AUC0–∞ (h μg mL−1) | 155 ± 4 | 104 ± 20 | 90 ± 6 | 99 ± 13 | 105 ± 14 |
| tmax (h) | 0.21 [0.15; 0.33] | 0.67 [0.50; 0.67]* | 0.33 [0.33; 0.67] | 0.33 [0.21; 0.22] | |
| Cmax (μg mL−1) | 76 ± 6 | 49 ± 4* | 58 ± 7 | 72 ± 5 | |
| CL (mL h−1 kg−1) | 775 ± 22 | 1413 ± 277 | 1354 ± 87 | 1318 ± 174 | 1294 ± 223 |
| ke (h−1) | 1.1 ± 0.0 | 2.2 ± 0.6 | 1.4 ± 0.3 | 1.6 ± 0.3 | 2.8 ± 0.8 |
| Fabs (%) | 100 ± 3 | 67 ± 13 | 58 ± 4 | 64 ± 8 | 67 ± 9 |
Cmax, AUC0–∞, CL, ke and Fabs are expressed as mean ± SEM, tmax is expressed as the median [Q1; Q3] (25% and 75% percentile) from six rats.
Significant difference from oral administration of 120 mg kg−1 acetaminophen (P < 0.05).